Register or Sign in to Save this opportunity, or Send an Inquiry.
Esmolol 100mg/10ml Vial
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine.
Send an Inquiry
RE:
Participants
You

Esmolol is an ultra fast acting beta1-receptor blocker (cardio selective) with a very short elimination half-life of 9 minutes. This product is used for the short-term treatment of supraventricular tachycardia and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable (e.g. myocardial infarct). Target groups are anaesthetists and ICU-clinicians. Generic version.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country-specific or regional distribution contract.

FEATURED
Last Updated Sep 2013
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION
Company Logo

Opportunity Contact


Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833